United States Flu Vaccine Market Demonstrates Steady Growth, Led by Sanofi, GSK, Seqirus, AstraZeneca, and Pfizer | DataM Intelligence

The global Flu Vaccine Market reached USD 5.70 billion in 2024 and is projected to reach USD 10.74 billion by 2033, growing at a CAGR of 7.3% during the forecast period 2025-2033, according to DataM Intelligence.

United States: Recent Industry Developments

✅ In October 2025, Sanofi launched a new high-dose quadrivalent flu vaccine specifically designed for elderly populations.
✅ In October 2025, The CDC recommended universal influenza vaccination for all individuals aged 6 months and older, expanding market potential.
✅ In October 2025, Seqirus opened a new state-of-the-art manufacturing facility to increase cell-based flu vaccine production capacity.

Japan: Recent Industry Developments

✅ In October 2025, Japan's Ministry of Health approved a new adjuvant flu vaccine with enhanced efficacy for high-risk groups.
✅ In October 2025, Daiichi Sankyo partnered with international vaccine manufacturers to strengthen flu vaccine supply chain in Japan.
✅ In October 2025, A nationwide digital vaccination registry was implemented to track flu vaccine coverage and effectiveness.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/flu-vaccine-market?jd

Market Trends & Drivers

The Flu Vaccine Market is experiencing steady growth driven by increasing awareness of influenza prevention, expanding vaccination recommendations, and technological advancements in vaccine development. Key trends include the shift from trivalent to quadrivalent vaccines, development of cell-based and recombinant vaccines, and growing adoption of high-dose and adjuvant formulations. The COVID-19 pandemic heightened public awareness of respiratory illnesses, while government immunization programs and rising healthcare expenditure continue to drive market expansion.

Competitive Landscape

The market is dominated by established vaccine manufacturers with strong production capabilities and global distribution networks.

Sanofi Pasteur leads the market with its extensive flu vaccine portfolio including Fluzone, Flublok, and Vaxigrip Tetra.
GlaxoSmithKline plc (GSK) maintains a strong position with Fluarix and FluLaval quadrivalent vaccines.
Seqirus (CSL Limited) is a major player with cell-based Flucelvax and adjuvant MF59-containing Fluad vaccines.
AstraZeneca PLC focuses on innovative vaccine delivery and new formulation development.
Pfizer Inc. produces and distributes flu vaccines through its established pharmaceutical networks.
Sinovac Biotech Ltd. supplies flu vaccines to emerging markets and expands global presence.
Mitsubishi Tanabe Pharma serves the Japanese market and explores international opportunities.
Daiichi Sankyo Company Limited develops and distributes flu vaccines in Japan and selected international markets.
Bharat Biotech focuses on developing cost-effective flu vaccines for emerging economies.
Green Cross Corporation supplies flu vaccines in Asian markets and invests in new technologies.

Segmentation

By Type (Whole virus vaccines, Split virus vaccines, Subunit vaccines, Live attenuated virus vaccines)
By Distribution Channel (Institutional, Hospitals, Community Clinics, Public Health Agencies, Workplaces, Retails, Retail Pharmacy, Mail Order Pharmacy)
By Application (For Children below 3 years, For Adults and Children over 3 years)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/flu-vaccine-market?jd

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?jd

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us:
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us:
DataM Intelligence is a market research and consulting firm that bridges the gap between data and decisive action. We specialize in translating top market trends and in-depth analysis into swift, smart solutions for your business.
With a repository of 6,300+ reports across 40+ industries, we provide the robust intelligence that over 200 companies in 50+ countries rely on to power their growth.

This release was published on openPR.